Tropisetron
- Level
- Commodity
- Parent
- 51171800
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171853This classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula C17H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6I819NIK1W, chemically known as 1h-indole-3-carboxylic acid, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo- but generally known as tropisetron, which bears US NIH Compound Identifier 72165. European Medicines Agency schedules Tropisetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11345MIG. The term TROPISETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules tropisetron in its Anatomical Therapeutic Chemical (ATC) Classification. TROPISETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tropisetron under HS 29399900 and SITC 54149. As of Q4 2014, TROPISETRON remains the US FDA Preferred Term for this commodity. Tropisetron bears US NLM identifiers UMLS ID C0063322 and NCI Concept Code C1131. SMILES: O(C1CC2N(C(CC2)C1)C)C(=O)C1C2C([NH]C1)CCCC2.
Same parent
Under 51171800 · 49Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.